Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-001649
Filing Date
2019-01-22
Accepted
2019-01-22 17:54:56
Documents
1
Period of Report
2019-01-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11054
  Complete submission text file 0000899243-19-001649.txt   12572
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INFINERA CORPORATION 140 CASPIAN COURT SUNNYVALE CA 94089
Business Address
Welch David F (Reporting) CIK: 0001399122 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-49908 | Film No.: 19536161